EA201492259A1 - Терапевтические применения фракций мастиковой смолы - Google Patents
Терапевтические применения фракций мастиковой смолыInfo
- Publication number
- EA201492259A1 EA201492259A1 EA201492259A EA201492259A EA201492259A1 EA 201492259 A1 EA201492259 A1 EA 201492259A1 EA 201492259 A EA201492259 A EA 201492259A EA 201492259 A EA201492259 A EA 201492259A EA 201492259 A1 EA201492259 A1 EA 201492259A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- mastic resin
- therapeutic applications
- resin fractions
- mastic
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/745—Polymers of hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
Abstract
Изобретение относится к применению в терапии мастиковой смолы и соединений, обнаруженных в мастиковой смоле, включая полимер мирцена. Конкретнее, изобретение относится к способам лечения нарушенной неврологической функции при помощи композиций, содержащих полимер мирцена.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15721509P | 2009-03-04 | 2009-03-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201492259A1 true EA201492259A1 (ru) | 2015-04-30 |
Family
ID=42224206
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201190168A EA021886B1 (ru) | 2009-03-04 | 2010-03-04 | Выделенная фракция мастиковой смолы |
EA201492259A EA201492259A1 (ru) | 2009-03-04 | 2010-03-04 | Терапевтические применения фракций мастиковой смолы |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201190168A EA021886B1 (ru) | 2009-03-04 | 2010-03-04 | Выделенная фракция мастиковой смолы |
Country Status (12)
Country | Link |
---|---|
US (4) | US8956601B2 (ru) |
EP (1) | EP2403505B8 (ru) |
CN (2) | CN102413833B (ru) |
AU (1) | AU2010220056B2 (ru) |
BR (1) | BRPI1013223A2 (ru) |
CA (2) | CA2974805C (ru) |
DK (1) | DK2403505T3 (ru) |
EA (2) | EA021886B1 (ru) |
ES (1) | ES2617875T3 (ru) |
HU (1) | HUE032032T2 (ru) |
PL (1) | PL2403505T3 (ru) |
WO (1) | WO2010100650A2 (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010100651A2 (en) | 2009-03-04 | 2010-09-10 | Regenera Pharma Ltd. | Compositions of polymeric myrcene |
EP2493461B9 (en) * | 2009-10-28 | 2016-05-18 | Regenera Pharma Ltd. | Polymeric monoterpenes for treating impaired neurological function |
PL2613777T3 (pl) | 2010-09-07 | 2019-10-31 | Regenera Pharma Ltd | Kompozycje zawierające kwasowe ekstrakty mastyksu |
US20150246087A1 (en) * | 2012-06-11 | 2015-09-03 | Regenera Pharma Ltd. | Extracts and therapeutic uses thereof |
US10376548B2 (en) * | 2013-10-11 | 2019-08-13 | Absorbezz, Llc | Animal health improvement composition and method |
KR101645721B1 (ko) * | 2014-12-30 | 2016-08-05 | 대전대학교 산학협력단 | 위장질환 예방 및 치료용 유향 함유 조성물 |
IL237621A0 (en) * | 2015-03-08 | 2015-06-30 | Regenera Pharma Ltd | Use of isolated fractions of the gum goddess to treat optic neuropathy |
ES2904263T3 (es) | 2015-09-24 | 2022-04-04 | Regenera Pharma Ltd | Composiciones que comprenden triterpenoides para el tratamiento de la enfermedad de Alzheimer y la enfermedad de Parkinson |
CN108289907A (zh) * | 2015-09-24 | 2018-07-17 | 瑞吉纳拉制药公司 | 包含三萜类的组合物 |
CA3036036A1 (en) * | 2016-09-08 | 2018-03-15 | Regenera Pharma Ltd. | Compositions comprising triterpenoids and uses thereof for treating optic neuropathy |
JP7074352B2 (ja) * | 2016-09-08 | 2022-05-24 | レジネラ ファーマ リミテッド | 視神経症を処置するためのマスチックガムの酸性抽出物を含む組成物およびその使用 |
KR102300227B1 (ko) * | 2021-04-08 | 2021-09-09 | 주식회사 프롬바이오 | 매스틱 검 수용액을 포함하는 탈모 방지 및 발모 촉진용 화장료 조성물 |
KR102328824B1 (ko) * | 2021-07-12 | 2021-11-23 | 주식회사 프롬바이오 | 수용화 매스틱 검과 감태나무 추출물을 이용한 발모 촉진 또는 탈모 억제용 조성물 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4374957A (en) | 1981-10-29 | 1983-02-22 | Michigan Molecular Institute | Triblock polymers of a monovinyl aromatic compound and myrcene |
US4564718A (en) | 1984-08-14 | 1986-01-14 | The University Of Manchester Institute Of Science And Technology | Functionally terminated polymers from terpene monomers and their applications |
US4713243A (en) | 1986-06-16 | 1987-12-15 | Johnson & Johnson Products, Inc. | Bioadhesive extruded film for intra-oral drug delivery and process |
JPS63179908A (ja) | 1987-01-22 | 1988-07-23 | Japan Synthetic Rubber Co Ltd | ミルセン重合体およびその製造方法 |
DE3820218A1 (de) | 1988-06-14 | 1989-12-28 | Osama L M Dr Med Dr Rer N Omer | Phytotherapeutikum zur behandlung von depressivem syndrom |
US8178516B2 (en) * | 1992-06-30 | 2012-05-15 | Sylvan Labs, LLC | Compositions and method for treatment of chronic inflammatory diseases |
US5506406A (en) | 1993-05-17 | 1996-04-09 | Atomic Energy Corporation Of South Africa Ltd. | Method and apparatus for determining the concentration of a heavy element in a rock face |
US5759569A (en) | 1995-01-10 | 1998-06-02 | The Procter & Gamble Company | Biodegradable articles made from certain trans-polymers and blends thereof with other biodegradable components |
US5714007A (en) | 1995-06-06 | 1998-02-03 | David Sarnoff Research Center, Inc. | Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate |
GR950100243A (el) | 1995-06-28 | 1997-02-28 | �. �����- �. ����� �.�.�. | Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων. |
JPH10130254A (ja) | 1996-11-01 | 1998-05-19 | Jumoku Seiri Kinousei Butsushitsu Gijutsu Kenkyu Kumiai | ジヒドロクマリン系化合物およびエストロゲン作用剤 |
DE19646392A1 (de) | 1996-11-11 | 1998-05-14 | Lohmann Therapie Syst Lts | Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht |
GR1003541B (el) | 1999-05-11 | 2001-03-07 | Αντιμικροβιακη και αντιμυκητιακη δραση του εξαγομενου απο τα κλαδια, φυλλα και καρπο της μαστιχας χιου -pistacia lentiscus var chia-, μαστιχελαιου, για χρηση σε καλλυντικες, φαρμακευτικες και παραφαρμακευτικεσς εφαρμογες καθως και στην παραγωγη οδοντοτσι | |
GR1003550B (el) | 1999-09-22 | 2001-03-13 | Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων | |
US6623728B2 (en) | 2000-06-30 | 2003-09-23 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Cosmetic skin care compositions and containing gum mastic |
US7056491B2 (en) | 2000-11-08 | 2006-06-06 | Wisconsin Alumni Research Foundation | Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators |
GR1003868B (el) * | 2001-02-06 | 2002-04-19 | Lavipharm S.A. | Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους |
JP2004518707A (ja) | 2001-02-13 | 2004-06-24 | イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム | カロテノイドを充填されたリポソーム |
US6534548B1 (en) | 2001-10-02 | 2003-03-18 | Kimberly-Clark Worldwide, Inc. | Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria |
ATE441423T1 (de) | 2002-05-01 | 2009-09-15 | Lavipharm Sa | Verwendung von mastix und dessen ätherischen ílen zur verhinderung oder bekämpfung von mikrobieller infektionen |
JP2004083443A (ja) | 2002-08-23 | 2004-03-18 | Hideji Watanabe | マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法 |
EP1572752B1 (en) | 2002-12-20 | 2014-08-13 | ExxonMobil Chemical Patents Inc. | Polymerization processes |
JP5193424B2 (ja) | 2002-12-20 | 2013-05-08 | エクソンモービル・ケミカル・パテンツ・インク | 長鎖分子を実質的に含まないポリマー |
US20050074509A1 (en) * | 2003-10-02 | 2005-04-07 | Data Medica Padova S.P.A. | Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components |
US20070219141A1 (en) | 2003-12-08 | 2007-09-20 | David Jones | Plant Materials Extraction Method |
US7417103B2 (en) | 2004-03-04 | 2008-08-26 | Riken | Isotactic 3,4-isoprene-based polymer |
WO2005112967A2 (en) | 2004-05-19 | 2005-12-01 | Balfour Marketing Corp. | Anticancer activity of chios mastic gum |
EP1768742A4 (en) | 2004-07-06 | 2007-10-17 | Transpharma Medical Ltd | ADMINISTRATION SYSTEM FOR TRANSDERMAL IMMUNIZATION |
JP2008507527A (ja) | 2004-07-23 | 2008-03-13 | ウォルサム ライフ サイエンス カンパニー リミテッド | Zingiberzerumbet(L.)Smithの抗過敏性炎症及び抗アレルギー活性 |
EP1817941A4 (en) * | 2004-11-13 | 2009-11-11 | Metaproteomics Llc | COMPOSITIONS HAVING INHIBITION OF CYCLO-OXYGENASE-2 |
US20070036873A1 (en) | 2005-07-27 | 2007-02-15 | Shibnath Ghosal | Method of treatment or management of stress |
US20070148187A1 (en) * | 2005-12-27 | 2007-06-28 | Intact Enterprises, Inc. | Mastic gum composition for use as a dietary supplement in humans and animals |
CN100478335C (zh) * | 2006-11-30 | 2009-04-15 | 上海力智生化科技有限公司 | 一种环氧月桂烯的制备方法 |
AR060847A1 (es) | 2007-05-03 | 2008-07-16 | Spannagel Lucia Antonia | Formulacion a base de calendula, aloe y centella. |
WO2010100651A2 (en) | 2009-03-04 | 2010-09-10 | Regenera Pharma Ltd. | Compositions of polymeric myrcene |
-
2010
- 2010-03-04 HU HUE10712171A patent/HUE032032T2/en unknown
- 2010-03-04 DK DK10712171.7T patent/DK2403505T3/en active
- 2010-03-04 ES ES10712171.7T patent/ES2617875T3/es active Active
- 2010-03-04 US US13/254,394 patent/US8956601B2/en active Active
- 2010-03-04 EA EA201190168A patent/EA021886B1/ru not_active IP Right Cessation
- 2010-03-04 PL PL10712171T patent/PL2403505T3/pl unknown
- 2010-03-04 AU AU2010220056A patent/AU2010220056B2/en not_active Ceased
- 2010-03-04 WO PCT/IL2010/000183 patent/WO2010100650A2/en active Application Filing
- 2010-03-04 CN CN201080018569.0A patent/CN102413833B/zh not_active Expired - Fee Related
- 2010-03-04 BR BRPI1013223A patent/BRPI1013223A2/pt not_active IP Right Cessation
- 2010-03-04 CN CN201611216078.2A patent/CN106619700A/zh active Pending
- 2010-03-04 EA EA201492259A patent/EA201492259A1/ru unknown
- 2010-03-04 EP EP10712171.7A patent/EP2403505B8/en active Active
- 2010-03-04 CA CA2974805A patent/CA2974805C/en active Active
- 2010-03-04 CA CA2754564A patent/CA2754564C/en active Active
-
2014
- 2014-12-31 US US14/588,037 patent/US9364509B2/en not_active Expired - Fee Related
-
2016
- 2016-05-13 US US15/154,698 patent/US10251923B2/en active Active
-
2019
- 2019-02-27 US US16/287,542 patent/US20190192594A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2403505B1 (en) | 2016-12-07 |
CN102413833B (zh) | 2017-02-08 |
WO2010100650A2 (en) | 2010-09-10 |
EA021886B1 (ru) | 2015-09-30 |
CA2754564C (en) | 2017-09-12 |
CN102413833A (zh) | 2012-04-11 |
US20190192594A1 (en) | 2019-06-27 |
US9364509B2 (en) | 2016-06-14 |
EP2403505A2 (en) | 2012-01-11 |
US10251923B2 (en) | 2019-04-09 |
CA2974805C (en) | 2021-11-30 |
US20150110902A1 (en) | 2015-04-23 |
CN106619700A (zh) | 2017-05-10 |
PL2403505T3 (pl) | 2017-06-30 |
AU2010220056B2 (en) | 2015-04-02 |
BRPI1013223A2 (pt) | 2017-09-26 |
CA2974805A1 (en) | 2010-09-10 |
US8956601B2 (en) | 2015-02-17 |
WO2010100650A3 (en) | 2010-11-25 |
HUE032032T2 (en) | 2017-09-28 |
US20160287654A1 (en) | 2016-10-06 |
ES2617875T3 (es) | 2017-06-20 |
DK2403505T3 (en) | 2017-03-06 |
US20120003175A1 (en) | 2012-01-05 |
AU2010220056A1 (en) | 2011-10-13 |
EP2403505B8 (en) | 2017-03-15 |
EA201190168A1 (ru) | 2013-01-30 |
WO2010100650A4 (en) | 2011-02-03 |
CA2754564A1 (en) | 2010-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201492259A1 (ru) | Терапевтические применения фракций мастиковой смолы | |
EA201001847A1 (ru) | Соединения и композиции, применяемые для лечения малярии | |
EA201001372A1 (ru) | Формы рифаксимина и их применение | |
MX343135B (es) | Compuestos de tipo fumagilol y métodos de realización y uso de los mismos. | |
EA201792465A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201001639A1 (ru) | Композиции и способы их получения и применения | |
PH12014500053A1 (en) | Proteasome inhibitors | |
EA201491766A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201071169A1 (ru) | ГИДРОКСИМЕТИЛПИРРОЛИДИНЫ В КАЧЕСТВЕ АГОНИСТОВ АДРЕНЕРГИЧЕСКИХ РЕЦЕПТОРОВ β3 | |
EA201001329A1 (ru) | Соединения и композиции в качестве модуляторов активности gpr119 | |
EA201491617A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
EA201491412A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
AU2011328009A8 (en) | Compounds and methods for treating pain | |
EA201070544A1 (ru) | Новый класс терапевтических веществ, усиливающих диффузию низкомолекулярных соединений | |
MX349886B (es) | Moleculas de union anti-pseudomonas lectina pisum satinum (psl) y usos de las mismas. | |
CO6571886A2 (es) | Antagonistas de pcsk9 | |
MX2010008688A (es) | Anticuerpos anti-receptor de linfopoyetina estromal timica procesados por ingenieria. | |
EA201170465A1 (ru) | Способы лечения прогрессирующего множественного склероза | |
EA201291031A1 (ru) | Способ лечения ожирения с применением антиоксидантных модуляторов воспаления | |
WO2012034116A3 (en) | Small molecules as epigenetic modulators of lysine-specific demethylase 1 and methods of treating disorders | |
EA201170349A1 (ru) | Модуляторы mif | |
IN2012DN00971A (ru) | ||
JO2788B1 (en) | Amido phenoxyendazole compounds beneficial as C-MET inhibitors | |
EA200701995A1 (ru) | Способы уменьшения кальцификации |